SCHEMBL31349568

SCHEMBL31349568

O=C1CC(n2cnc3cc(Br)cc(C(F)(F)F)c32)CN1

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 2/20 0.41
▸ HCAR1 Q9BXC0 1/20 0.37
▸ SYK P43405 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31349528 0.86 ABL1 (0.42) ABL1
SCHEMBL31349532 0.82 ABL1 (0.41) ABL1
SCHEMBL31349450 0.78 ABL1 (0.36) ABL1
SCHEMBL31698362 0.78 ABL1 (0.37) ABL1HCAR1
SCHEMBL31349425 0.78 HCAR1 (0.33) HCAR1
SCHEMBL31698694 0.77 ABL1 (0.36) ABL1HCAR1
SCHEMBL31698880 0.76 PIK3CD (0.35) ABL1HCAR1
SCHEMBL31349589 0.75 MAP3K12 (0.36) HCAR1
SCHEMBL25319241 0.74 AR (0.39) HCAR1
SCHEMBL30507492 0.74 AR (0.39) HCAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743078-A2 APOL1 INHIBITORS AND METHODS OF USE Maze Therapeutics, Inc. (US) 2026-05-20 — — EP disclosed
WO-2025015104-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2025-01-16 — — WO disclosed
Send feedback